mTOR Inhibition Elicits a Dramatic Response in PI3K-Dependent Colon Cancers
Dustin A. Deming(University of Wisconsin–Madison), Richard B. Halberg(University of Wisconsin–Madison)
Cited by 22
Related Papers
PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors
|Oncogenesis|2015|75
Fisetin and 5‐fluorouracil: Effective combination for <i>PIK3CA</i>‐mutant colorectal cancer
|International Journal of Cancer|2019|41
Cyp1b1 Exerts Opposing Effects on Intestinal Tumorigenesis via Exogenous and Endogenous Substrates
|Cancer Research|2008|22
Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K
|PLoS ONE|2016|22